Richard Champlin

2.1k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Richard Champlin is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Richard Champlin has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 13 papers in Genetics and 7 papers in Oncology. Recurrent topics in Richard Champlin's work include Hematopoietic Stem Cell Transplantation (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Richard Champlin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Richard Champlin collaborates with scholars based in United States, Greece and Canada. Richard Champlin's co-authors include Hagop M. Kantarjian, Nancy A. Kernan, John A. Hansen, Robert C. Ash, Gordon L. Phillips, Jean Henslee-Downey, Jean E. Sanders, Philip B. McGlave, Jeffrey McCullough and E. Donnall Thomas and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Richard Champlin

30 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program

1993 658 citations Nancy A. Kernan, Glenn E. Bartsch et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Champlin United States	15	870	351	325	299	259	32	1.5k
Nicola Mordini Italy	23	1.2k 1.3×	338 1.0×	449 1.4×	387 1.3×	292 1.1×	52	1.7k
L Fisher United States	12	1.1k 1.2×	560 1.6×	362 1.1×	390 1.3×	233 0.9×	16	1.7k
Shigesaburo Miyakoshi Japan	26	982 1.1×	370 1.1×	596 1.8×	416 1.4×	211 0.8×	90	1.7k
UW Schaefer Germany	17	894 1.0×	330 0.9×	330 1.0×	248 0.8×	102 0.4×	35	1.3k
Ashok Srinivasan United States	19	650 0.7×	260 0.7×	289 0.9×	377 1.3×	276 1.1×	69	1.3k
Noriko Doki Japan	18	894 1.0×	278 0.8×	324 1.0×	203 0.7×	197 0.8×	181	1.5k
Hélène Schoemans Belgium	18	640 0.7×	224 0.6×	338 1.0×	265 0.9×	259 1.0×	69	1.3k
Woo-Sung Min South Korea	21	1.2k 1.3×	454 1.3×	435 1.3×	284 0.9×	129 0.5×	131	1.7k
A Schattenberg Netherlands	20	785 0.9×	274 0.8×	516 1.6×	181 0.6×	117 0.5×	35	1.3k
PJ Tutschka United States	19	1.1k 1.2×	337 1.0×	366 1.1×	226 0.8×	158 0.6×	42	1.5k

Countries citing papers authored by Richard Champlin

Since Specialization

Citations

This map shows the geographic impact of Richard Champlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Champlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Champlin more than expected).

Fields of papers citing papers by Richard Champlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Champlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Champlin. The network helps show where Richard Champlin may publish in the future.

Co-authorship network of co-authors of Richard Champlin

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Champlin. A scholar is included among the top collaborators of Richard Champlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Champlin. Richard Champlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khaled, Samer K., Jaap Jan Boelens, Mitchell S. Cairo, et al.. (2021). Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA). Transplantation and Cellular Therapy. 27(3). S24–S26. 2 indexed citations

Zeng, Zhihong, Wenbin Liu, Christopher B. Benton, et al.. (2019). Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation. Acta Haematologica. 142(3). 176–184. 2 indexed citations

Swaminathan, Mahesh, Sarah A. Bannon, Mark J. Routbort, et al.. (2019). Hematologic malignancies and Li–Fraumeni syndrome. Molecular Case Studies. 5(1). a003210–a003210. 50 indexed citations

Zhang, Xiaotao, Ming Sun, Suyu Liu, et al.. (2017). Risk factors for falls in older patients with cancer. BMJ Supportive & Palliative Care. 8(1). 34–37. 31 indexed citations

Rozovski, Uri, Ohad Benjamini, Preetesh Jain, et al.. (2015). Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure. Journal of Clinical Oncology. 33(14). 1557–1563. 18 indexed citations

Poon, Michelle, Patricia S. Fox, Barry I. Samuels, et al.. (2014). Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis. Leukemia & lymphoma. 56(3). 711–715. 9 indexed citations

Denzen, Ellen M., Navneet S. Majhail, Claudio Anasetti, et al.. (2012). Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative. Biology of Blood and Marrow Transplantation. 19(1). 4–11. 29 indexed citations

Ma, Wencai, Michael Wang, Zhiqiang Wang, et al.. (2010). Effect of Long-term Storage in TRIzol on Microarray-Based Gene Expression Profiling. Cancer Epidemiology Biomarkers & Prevention. 19(10). 2445–2452. 35 indexed citations

Champlin, Richard. (2010). Hematopoietic Stem Cell Transplantation for Treatment of Myleodysplastic Syndromes. Biology of Blood and Marrow Transplantation. 17(1). S6–S8.

10.

Wagner, John E., Richard Champlin, & Lawrence D. Petz. (2005). Symposium Summary. Biology of Blood and Marrow Transplantation. 11(11). 921–927. 1 indexed citations

11.

Zeng, Zhihong, Marina Konopleva, Billie Nowak, et al.. (2005). Disruption of Leukemia/Stroma Cell Interactions by CXCR4 Antagonist AMD3465 Enhances Chemotherapy-Induced Apoptosis in AML.. Blood. 106(11). 474–474. 6 indexed citations

12.

El-Zimaity, Maha, Rima M. Saliba, Ka‐Wah Chan, et al.. (2004). Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood. 103(12). 4674–4680. 77 indexed citations

13.

Wong, Raymond, Marcos de Lima, Daniel R. Couriel, et al.. (2003). Treatment of Relapsing Refractory Diffuse Large Cell Lymphoma After Matched Unrelated Donor Bone Marrow Transplant with Immunosuppression Withdrawal and Rituximab. Leukemia & lymphoma. 44(5). 829–832. 1 indexed citations

14.

Kontoyiannis, Dimitrios P., Ray Hachem, Russell E. Lewis, et al.. (2003). Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 98(2). 292–299. 223 indexed citations

15.

Champlin, Richard, Issa F. Khouri, & Sergio Giralt. (1999). Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: Induction of graft-vs.-malignancy as treatment for malignant diseases. Journal of Clinical Apheresis. 14(1). 45–49. 5 indexed citations

16.

Bachier, Carlos, Richard E. Giles, F. García‐Sánchez, et al.. (1999). Hematopoietic Retroviral Gene Marking in Patients with Follicular Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 32(3-4). 279–288. 17 indexed citations

17.

Schiller, Gary J., James Gajewski, Myung Lee, et al.. (1994). Benefit of High-Dose Cytarabine-Based Consolidation Chemotherapy for Adults with Acute Myelogenous Leukemia. Leukemia & lymphoma. 15(1-2). 85–90. 2 indexed citations

18.

Kernan, Nancy A., Glenn E. Bartsch, Robert C. Ash, et al.. (1993). Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program. New England Journal of Medicine. 328(9). 593–602. 658 indexed citations breakdown →

19.

Deisseroth, Albert, Hagop M. Kantarjian, Moshe Talpaz, et al.. (1993). Molecular approaches to the diagnosis and treatment of cancer. Stem Cells. 11(S3). 129–130. 1 indexed citations

20.

Seong, David, Pu Liu, Ying Zhao, et al.. (1993). Detection of variant Ph-positive chronic myelogenous leukemia involving chromosomes 1, 9, and 22 by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics. 65(2). 100–103. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact